FDA Inspection 883317 — Adare Pharmaceuticals Srl

Adare Pharmaceuticals Srl — FEI 1000573478

The FDA completed an inspection of Adare Pharmaceuticals Srl on May 30, 2014 in Pessano Con Bornago. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 30, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pessano Con Bornago (Italy)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
121521 CFR 211.67(b)Written procedures not established/followed
126321 CFR 211.68(b)Computer control of master formula records
360321 CFR 211.160(b)Scientifically sound laboratory controls